Thymosin Beta-4 Protects Corneal Cells from Ethanol-Induced Damage
Thymosin beta-4 protected corneal stromal cells from ethanol-induced oxidative stress and apoptosis while promoting cell proliferation and wound healing in both cell and mouse models.
Quick Facts
What This Study Found
Thymosin beta-4 alleviated ethanol-induced oxidative stress and apoptosis in human corneal keratocytes by upregulating protective factors (Bcl-2, catalase, CuZnSOD) and inhibiting the cell death marker Caspase-3. Tβ4 also promoted cell proliferation through upregulated Ki67 expression and accelerated corneal wound healing in both in vitro and in vivo models. In mouse corneas treated with ethanol, Tβ4 promoted reconstruction of the damaged corneal stroma, confirmed by fluorescein sodium staining and histological examination.
Key Numbers
How They Did This
Researchers used human corneal keratocytes (HCKs) and BALB/c mice to create ethanol injury models both in vitro and in vivo. Cell metabolic activity was measured with CCK-8 assay. Reactive oxygen species were detected using DCFH-DA. Apoptosis was assessed by TUNEL staining. Cell proliferation and migration were measured with wound healing insert assays. In mice, corneal healing was tracked with fluorescein staining and H&E histology. Gene and protein expression were analyzed by RT-qPCR, ELISA, and immunostaining.
Why This Research Matters
Corneal damage from ethanol exposure during eye surgery is a real clinical problem. This research suggests thymosin beta-4 could be developed as a protective eye drop or treatment to reduce corneal damage and speed recovery after procedures that involve alcohol contact with the cornea.
The Bigger Picture
Thymosin beta-4 is already known for promoting wound healing in various tissues. This study extends its therapeutic potential to ophthalmology, specifically corneal surgery recovery. With Tβ4 eye drops (RegeneRx's RGN-259) already in clinical trials for dry eye disease, demonstrating protective effects against surgical corneal injury could broaden its clinical applications.
What This Study Doesn't Tell Us
The study used cell culture and mouse models, which may not fully replicate human corneal healing. Specific dosing, treatment timing, and concentration-response relationships were not detailed in the abstract. Long-term safety and efficacy of Tβ4 for corneal applications were not assessed. The mouse cornea differs from the human cornea in size and structure.
Questions This Raises
- ?Could Tβ4 eye drops be used prophylactically before LASIK or other corneal procedures to prevent ethanol damage?
- ?What is the optimal concentration and timing of Tβ4 application for maximum corneal protection?
- ?Does Tβ4's corneal protection extend to other types of surgical or chemical injury beyond ethanol?
Trust & Context
- Key Stat:
- Both in vitro and in vivo protection Tβ4 showed consistent protective effects in human corneal cells and mouse corneas, strengthening the case for clinical translation
- Evidence Grade:
- This is a preclinical study using both cell culture and animal models with multiple validated assays. The dual-model approach strengthens confidence, but human clinical data is still needed.
- Study Age:
- Published in 2022, this study builds on established thymosin beta-4 wound healing research and is relevant to ongoing clinical development of Tβ4 eye drops.
- Original Title:
- Protection effect of thymosin β4 on ethanol injury in corneal stromal keratocyte.
- Published In:
- BMC ophthalmology, 22(1), 33 (2022)
- Authors:
- Liu, Jinghua, Guo, Chen(4), Hao, Peng, Wang, Peihong, Li, Linghan, Wang, Yuchuan, Li, Xuan
- Database ID:
- RPEP-06322
Evidence Hierarchy
Frequently Asked Questions
How does thymosin beta-4 protect corneal cells?
Tβ4 activates protective genes (Bcl-2, catalase, CuZnSOD) that fight oxidative stress and prevent cell death, while inhibiting the cell death trigger Caspase-3. It also boosts cell proliferation through Ki67 upregulation, helping damaged corneal tissue rebuild faster.
Could this lead to better recovery after eye surgery?
Potentially, yes. Eye procedures like LASIK sometimes use ethanol on the cornea, which can damage deeper tissue layers. If Tβ4 can protect against this damage, it could be developed as a pre-surgical or post-surgical eye drop treatment to speed recovery and reduce complications.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06322APA
Liu, Jinghua; Guo, Chen; Hao, Peng; Wang, Peihong; Li, Linghan; Wang, Yuchuan; Li, Xuan. (2022). Protection effect of thymosin β4 on ethanol injury in corneal stromal keratocyte.. BMC ophthalmology, 22(1), 33. https://doi.org/10.1186/s12886-022-02255-8
MLA
Liu, Jinghua, et al. "Protection effect of thymosin β4 on ethanol injury in corneal stromal keratocyte.." BMC ophthalmology, 2022. https://doi.org/10.1186/s12886-022-02255-8
RethinkPeptides
RethinkPeptides Research Database. "Protection effect of thymosin β4 on ethanol injury in cornea..." RPEP-06322. Retrieved from https://rethinkpeptides.com/research/liu-2022-protection-effect-of-thymosin
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.